{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:39:13Z","timestamp":1754163553536,"version":"3.41.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,31]]},"DOI":"10.7759\/cureus.89102","type":"journal-article","created":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:15:40Z","timestamp":1753946140000},"source":"Crossref","is-referenced-by-count":0,"title":["Molecular Aspects of Rare Coagulation Factor Deficiencies"],"prefix":"10.7759","author":[{"given":"Hajar","family":"Tourbih","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Harrach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa","family":"Bencharef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hind","family":"Dehbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bouchra","family":"Oukkache","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Thesis: Determining the pathophysiological mechanisms of rare coagulation abnormalities using in vitro models and innovative genetic approaches. Claude Bernard university - Lyon 1. (2017). Accessed: April 15,2024","author":"Jourdy Y","year":"2017","unstructured":"Jourdy Y. Determining the pathophysiological mechanisms of rare coagulation abnormalities using in vitro models and innovative genetic approaches (Thesis). Claude Bernard university - Lyon 1, 2017. https:\/\/theses.hal.science\/tel-01696105\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12402","article-title":"Rare bleeding disorders-bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency","volume":"20 Suppl 4","author":"James P","year":"2014","unstructured":"James P, Salomon O, Mikovic D, Peyvandi F. Rare bleeding disorders-bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia. 2014, 20 Suppl 4:71-5. 10.1111\/hae.12402","journal-title":"Haemophilia"},{"key":"ref3","article-title":"Rare bleeding disorders","volume":"5","author":"de Raucourt E","year":"2015","unstructured":"de Raucourt E. Rare bleeding disorders. Horizons Hemato. 2015, 5:133-5.","journal-title":"Horizons Hemato"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.annfar.2013.01.019","article-title":"Rare bleeding disorders and invasive procedures (Article in French)","volume":"32","author":"Bonhomme F","year":"2013","unstructured":"Bonhomme F, Schved JF, Giansily-Blaizot M, Samama CM, de Moerloose P. Rare bleeding disorders and invasive procedures (Article in French). Ann Fr Anesth Reanim. 2013, 32:198-205. 10.1016\/j.annfar.2013.01.019","journal-title":"Ann Fr Anesth Reanim"},{"key":"ref5","article-title":"Polymerase chain reaction (PCR)","author":"Khehra N","year":"2025","unstructured":"Khehra N, Padda IS, Swift CJ. Polymerase chain reaction (PCR). StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref6","article-title":"Thesis: Development of PCR approaches and implementation to improve access to molecular diagnosis of infectious diseases in resource-limited countries. University of Montpellier. (2018). Accessed: April 09,2025","author":"Sylvie Zida","year":"2018","unstructured":"Sylvie Zida. Development of PCR approaches and implementation to improve access to molecular diagnosis of infectious diseases in resource-limited countries (Thesis). University of Montpellier, 2018. https:\/\/theses.hal.science\/tel-01809529v1\/file\/2018_ZIDA_archivage.pdf."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153443","article-title":"Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19","volume":"221","author":"Teymouri M","year":"2021","unstructured":"Teymouri M, Mollazadeh S, Mortazavi H, et al.. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol Res Pract. 2021, 221:153443. 10.1016\/j.prp.2021.153443","journal-title":"Pathol Res Pract"},{"key":"ref8","unstructured":"PCR limitations in PRRS diagnostics. (2018). https.\/\/www.pig333.com\/articles\/pcr-limitations-in-prrs-diagnostics_14136\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1773-035X(20)30313-0","article-title":"Biological diagnosis of Sars-CoV-2 infection: strategies and interpretation of results (Article in French)","volume":"2020","author":"Hantz S","year":"2020","unstructured":"Hantz S. Biological diagnosis of Sars-CoV-2 infection: strategies and interpretation of results (Article in French). Rev Francoph Lab. 2020, 2020:48-56. 10.1016\/S1773-035X(20)30313-0","journal-title":"Rev Francoph Lab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.immbio.2008.07.016","article-title":"Les techniques de s\u00e9quen\u00e7age de l\u2019ADN\u00a0: une r\u00e9volution en marche. Premi\u00e8re partie (Article in French)","volume":"23","author":"Lamoril J","year":"2008","unstructured":"Lamoril J, Ameziane N, Deybach JC, Bouizegar\u00e8ne P, Bogard M. Les techniques de s\u00e9quen\u00e7age de l\u2019ADN\u00a0: une r\u00e9volution en marche. Premi\u00e8re partie (Article in French). Immuno-analyse &amp; Biologie Sp\u00e9cialis\u00e9e. 2008, 23:260-79. 10.1016\/j.immbio.2008.07.016","journal-title":"Immuno-analyse & Biologie Sp\u00e9cialis\u00e9e"},{"key":"ref11","unstructured":"Sanger sequencing. (2022). Accessed.  April 17, 2025: https:\/\/www.genomicseducation.hee.nhs.uk\/genotes\/knowledge-hub\/sanger-sequencing\/."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.11610.1","article-title":"Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome","volume":"6","author":"Totomoch-Serra A","year":"2017","unstructured":"Totomoch-Serra A, Marquez MF, Cervantes-Barrag\u00e1n DE. Sanger sequencing as a first-line approach for molecular diagnosis of Andersen-Tawil syndrome. F1000Res. 2017, 6:1016. 10.12688\/f1000research.11610.1","journal-title":"F1000Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/v13061125","article-title":"HIV-1 drug resistance genotyping in resource limited settings: current and future perspectives in sequencing technologies","volume":"13","author":"Manyana S","year":"2021","unstructured":"Manyana S, Gounder L, Pillay M, Manasa J, Naidoo K, Chimukangara B. HIV-1 drug resistance genotyping in resource limited settings: current and future perspectives in sequencing technologies. Viruses. 2021, 13:10.3390\/v13061125","journal-title":"Viruses"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1711801","article-title":"Next-generation sequencing to diagnose suspected genetic disorders","volume":"379","author":"Adams DR","year":"2018","unstructured":"Adams DR, Eng CM. Next-generation sequencing to diagnose suspected genetic disorders. N Engl J Med. 2018, 379:1353-62. 10.1056\/NEJMra1711801","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10020347","article-title":"Familial multiple coagulation factor deficiencies (FMCFDs) in a large cohort of patients - a single-center experience in genetic diagnosis","volume":"10","author":"Preisler B","year":"2021","unstructured":"Preisler B, Pezeshkpoor B, Banchev A, et al.. Familial multiple coagulation factor deficiencies (FMCFDs) in a large cohort of patients - a single-center experience in genetic diagnosis. J Clin Med. 2021, 10:10.3390\/jcm10020347","journal-title":"J Clin Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2024.102477","article-title":"Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study","volume":"8","author":"Willems SP","year":"2024","unstructured":"Willems SP, Simons A, Saes JL, et al.. Targeted exome analysis in patients with rare bleeding disorders: data from the Rare Bleeding Disorders in the Netherlands study. Res Pract Thromb Haemost. 2024, 8:102477. 10.1016\/j.rpth.2024.102477","journal-title":"Res Pract Thromb Haemost"},{"key":"ref17","unstructured":"Genetic analysis of 527 cases of rare bleeding disorders. EAHAD 2025. (2025). Accessed: July 01, 2025: https:\/\/www.emjreviews.com\/hematology\/news\/genetic-analysis-of-527-cases-of-rare-bleeding-disorders-eahad-2025\/."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-05-505511","article-title":"Genetic sequence analysis of inherited bleeding diseases","volume":"122","author":"Peyvandi F","year":"2013","unstructured":"Peyvandi F, Kunicki T, Lillicrap D. Genetic sequence analysis of inherited bleeding diseases. Blood. 2013, 122:3423-31. 10.1182\/blood-2013-05-505511","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1349222","article-title":"Congenital fibrinogen disorders: an update","volume":"39","author":"de Moerloose P","year":"2013","unstructured":"de Moerloose P, Casini A, Neerman-Arbez M. Congenital fibrinogen disorders: an update. Semin Thromb Hemost. 2013, 39:585-95. 10.1055\/s-0033-1349222","journal-title":"Semin Thromb Hemost"},{"key":"ref20","article-title":"Thesis: Diagnosis of coagulopathy: traditional method versus rapid diagnostic tests. UFR of pharmaceutical sciences. University of Bordeaux. (2017). Accessed: April 24,2024","author":"C\u00e9line C","year":"2017","unstructured":"C\u00e9line C. Diagnosis of coagulopathy: traditional method versus rapid diagnostic tests (Thesis). University of Bordeaux, 2017. https:\/\/dumas.ccsd.cnrs.fr\/dumas-01473167v1."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1684\/abc.2016.1167","article-title":"Diagnosis of congenital fibrinogen disorders","volume":"74","author":"Lebreton A","year":"2016","unstructured":"Lebreton A, Casini A. Diagnosis of congenital fibrinogen disorders. Ann Biol Clin (Paris). 2016, 74:405-12. 10.1684\/abc.2016.1167","journal-title":"Ann Biol Clin (Paris)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010100","article-title":"Identification of two novel fibrinogen B\u03b2 chain mutations in two Slovak families with quantitative fibrinogen disorders","volume":"19","author":"Simurda T","year":"2017","unstructured":"Simurda T, Zolkova J, Snahnicanova Z, et al.. Identification of two novel fibrinogen B\u03b2 chain mutations in two Slovak families with quantitative fibrinogen disorders. Int J Mol Sci. 2017, 19:10.3390\/ijms19010100","journal-title":"Int J Mol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1348948","article-title":"Congenital prothrombin deficiency: an update","volume":"39","author":"Lancellotti S","year":"2013","unstructured":"Lancellotti S, Basso M, De Cristofaro R. Congenital prothrombin deficiency: an update. Semin Thromb Hemost. 2013, 39:596-606. 10.1055\/s-0033-1348948","journal-title":"Semin Thromb Hemost"},{"key":"ref24","article-title":"Prothrombin (Factor II) deficiency as a rare bleeding disorder","volume":"9","author":"Albalawi MA","unstructured":"Albalawi MA. Prothrombin (Factor II) deficiency as a rare bleeding disorder. J Adv Pharm Edu Res. 9:109-13.","journal-title":"J Adv Pharm Edu Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/1076029618770741","article-title":"Prothrombin: another clotting factor after FV that is involved both in bleeding and thrombosis","volume":"24","author":"Girolami A","year":"2018","unstructured":"Girolami A, Cosi E, Ferrari S, Girolami B. Prothrombin: another clotting factor after FV that is involved both in bleeding and thrombosis. Clin Appl Thromb Hemost. 2018, 24:845-9. 10.1177\/1076029618770741","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1225759","article-title":"Congenital prothrombin deficiency","volume":"35","author":"Lancellotti S","year":"2009","unstructured":"Lancellotti S, De Cristofaro R. Congenital prothrombin deficiency. Semin Thromb Hemost. 2009, 35:367-81. 10.1055\/s-0029-1225759","journal-title":"Semin Thromb Hemost"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-012-1442-1","article-title":"Prothrombin Mumbai causes severe prothrombin deficiency due to a novel Cys90Ser mutation","volume":"91","author":"Kulkarni B","year":"2012","unstructured":"Kulkarni B, Kanakia S, Ghosh K, Shetty S. Prothrombin Mumbai causes severe prothrombin deficiency due to a novel Cys90Ser mutation. Ann Hematol. 2012, 91:1667-8. 10.1007\/s00277-012-1442-1","journal-title":"Ann Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108683","article-title":"Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review","volume":"9","author":"Kulkarni BP","year":"2014","unstructured":"Kulkarni BP, Nair SB, Vijapurkar M, et al.. Molecular pathology of rare bleeding disorders (RBDs) in India: a systematic review. PLoS One. 2014, 9:e108683. 10.1371\/journal.pone.0108683","journal-title":"PLoS One"},{"article-title":"Thesis: Coagulation Factor V, Physiology and Related Pathologies. Faculty of Medicine and Pharmacy - Rabat. Mohammed University V. (2023). Accessed: June 28,2024","author":"Ismail R","key":"ref29","unstructured":"Ismail R. Coagulation factor V, physiology and related pathologies (Thesis). Mohammed University V, Rabat; https:\/\/toubkal.imist.ma\/bitstream\/handle\/123456789\/19341\/P0542023.pdf."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.22037\/jcma.v1i2.10790","article-title":"Laboratory diagnosis of congenital factor V deficiency, routine, specific coagulation tests with molecular methods","volume":"1","author":"Tabibian S","year":"2016","unstructured":"Tabibian S, Kazemi A, Dorgalaleh A. Laboratory diagnosis of congenital factor V deficiency, routine, specific coagulation tests with molecular methods. J Cell Mol Anesth. 2016, 1:87-90. 10.22037\/jcma.v1i2.10790","journal-title":"J Cell Mol Anesth"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1349224","article-title":"Parahemophilia: new insights into factor v deficiency","volume":"39","author":"Thalji N","year":"2013","unstructured":"Thalji N, Camire RM. Parahemophilia: new insights into factor v deficiency. Semin Thromb Hemost. 2013, 39:607-12. 10.1055\/s-0033-1349224","journal-title":"Semin Thromb Hemost"},{"key":"ref32","article-title":"Factor VII constitutional deficiency: singularity of a family case","volume":"2018","author":"Azzahraa MF","unstructured":"Azzahraa MF, Loubna Z, Khalil H. Factor VII constitutional deficiency: singularity of a family case. Int J Med Sci Health Res. 2018:108-11.","journal-title":"Int J Med Sci Health Res"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1684\/hma.2017.1268","article-title":"Coagulation factor VII variants: which thromboplastin should be used to assay its activity?","volume":"23","author":"Giansily-Blaizot M","year":"2017","unstructured":"Giansily-Blaizot M, Chamouni P, Tachon G, Buthiau D, El Jeljal-Abakarim N, Martin-Toutain I, Pellequer JL. Coagulation factor VII variants: which thromboplastin should be used to assay its activity?. Hematology. 2017, 23:181-7. 10.1684\/hma.2017.1268","journal-title":"Hematology"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2019.33.212.13226","article-title":"Congenital factor VII deficiency revealed by post-circumcision bleeding (Article in French)","volume":"33","author":"Ettarfaoui M","year":"2019","unstructured":"Ettarfaoui M, Ghissassi SE, Barkat A. Congenital factor VII deficiency revealed by post-circumcision bleeding (Article in French). Pan Afr Med J. 2019, 33:212. 10.11604\/pamj.2019.33.212.13226","journal-title":"Pan Afr Med J"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.11604\/pamj-cm.2020.3.173.23140","article-title":"Incidental discovery of factor VII deficiency: a clinical-biological dialogue is recommended","volume":"3","author":"Esselmani H","year":"2020","unstructured":"Esselmani H, Akhatar B, Al Mabrouki Y, El Rhrib M. Incidental discovery of factor VII deficiency: a clinical-biological dialogue is recommended. PAMJ Clinical Medicine. 2020, 3:10.11604\/pamj-cm.2020.3.173.23140","journal-title":"PAMJ Clinical Medicine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2019.09.006","article-title":"Clinical and laboratory diagnosis of rare coagulation disorders (RCDs)","volume":"196","author":"Menegatti M","year":"2020","unstructured":"Menegatti M, Palla R. Clinical and laboratory diagnosis of rare coagulation disorders (RCDs). Thromb Res. 2020, 196:603-8. 10.1016\/j.thromres.2019.09.006","journal-title":"Thromb Res"},{"key":"ref37","article-title":"Thesis: Constitutional coagulation factor X deficiency in a family and literature review. Faculty of medicine and pharmacy - Fes. Sidi Mohammed Ben Abdellah university. (2011). Accessed: July 05,2024","author":"Meryem TR","year":"2011","unstructured":"Meryem TR. Constitutional coagulation factor X deficiency in a family and literature review (Thesis). Sidi Mohamed Ben Abdellah University, 2011. https:\/\/toubkal.imist.ma\/bitstream\/handle\/123456789\/22475\/140-11.pdf."},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-021-02456-w","article-title":"Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics","volume":"52","author":"Camire RM","year":"2021","unstructured":"Camire RM. Blood coagulation factor X: molecular biology, inherited disease, and engineered therapeutics. J Thromb Thrombolysis. 2021, 52:383-90. 10.1007\/s11239-021-02456-w","journal-title":"J Thromb Thrombolysis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.11746","article-title":"Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency","volume":"93","author":"Bereczky Z","year":"2008","unstructured":"Bereczky Z, B\u00e1rdos H, Kom\u00e1romi I, et al.. Factor XDebrecen: Gly204Arg mutation in factor X causes the synthesis of a non-secretable protein and severe factor X deficiency. Haematologica. 2008, 93:299-302. 10.3324\/haematol.11746","journal-title":"Haematologica"},{"key":"ref40","unstructured":"Strategies for studying genes involved in rare constitutional coagulation factor deficiencies (excluding hemophilia A and B and Willebrand disease). Accessed. July 05, 2024: https:\/\/anpgm.fr\/media\/documents\/ANPGM_135-deficits_constitutionnels_rares_en_facteurs_de_coagulation_avr..._oRtZsaV.pdf."},{"key":"ref41","doi-asserted-by":"crossref","DOI":"10.1016\/S0929-693X(10)70821-6","article-title":"P427 - Trois cas de d\u00e9ficit constitutionnel en facteur X au sein d\u2019une m\u00eame famille","volume":"17","author":"Khabbache K","year":"2010","unstructured":"Khabbache K, Alaoui K, Atmani S, Oulmaati A, Hida M, Bouharrou A. P427 - Trois cas de d\u00e9ficit constitutionnel en facteur X au sein d\u2019une m\u00eame famille. Archives de P\u00e9diatrie. 2010, 17:157.","journal-title":"Archives de P\u00e9diatrie"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2739\/kurumemedj.MS6300007","article-title":"Factor X deficiency with heterozygous mutations of novel p.G435S and known p.G244R in a patient presenting with severe umbilical hemorrhage","volume":"63","author":"Matsuo Y","year":"2017","unstructured":"Matsuo Y, Mizuochi T, Miho M, et al.. Factor X deficiency with heterozygous mutations of novel p.G435S and known p.G244R in a patient presenting with severe umbilical hemorrhage. Kurume Med J. 2017, 63:23-8. 10.2739\/kurumemedj.MS6300007","journal-title":"Kurume Med J"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1684\/hma.2010.0478","article-title":"Factor XI deficiency","volume":"16","author":"de Raucourt E","year":"2010","unstructured":"de Raucourt E, Bauduer F, Pan-Petesch B, Goudemand J. Factor XI deficiency. Hematology. 2010, 16:284-92. 10.1684\/hma.2010.0478","journal-title":"Hematology"},{"key":"ref44","article-title":"Thesis: Coagulation factor XI deficiency. Faculty of medicine and pharmacy - Rabat. Mohammed V university","author":"Nadim C","year":"2018","unstructured":"Nadim C. Coagulation factor XI deficiency (Thesis) Faculty of medicine and pharmacy. Mohammed V University, Rabat; 2018. https:\/\/toubkal.imist.ma\/bitstream\/handle\/123456789\/28823\/M2892018.pdf."},{"key":"ref45","article-title":"Thesis: Value of the thrombin generation test in factor XI deficiency. Rouen Normandy health department","author":"Kasonga F","year":"2020","unstructured":"Kasonga F. Value of the thrombin generation test in factor XI deficiency (Thesis). Rouen Normandy Health Department, 2020. https:\/\/dumas.ccsd.cnrs.fr\/dumas-03051849v1."},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044-1792033","article-title":"Laboratory and molecular diagnosis of factor XI deficiency","volume":"51","author":"Davidson S","year":"2025","unstructured":"Davidson S, Gomez K. Laboratory and molecular diagnosis of factor XI deficiency. Semin Thromb Hemost. 2025, 51:145-54. 10.1055\/s-0044-1792033","journal-title":"Semin Thromb Hemost"},{"key":"ref47","article-title":"Thesis: Involvement of coagulation factor XIII in maintaining pregnancy. university of Versailles, Saint-Quentin-en-Yvelines - Department of health sciences, Simone Veil. (2015). Accessed: November 04,2024","author":"Daou C","year":"2015","unstructured":"Daou C. Involvement of coagulation factor XIII in maintaining pregnancy. University of Versailles, 2015. https:\/\/dumas.ccsd.cnrs.fr\/dumas-01228051v1."},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1684\/hma.2020.1571","article-title":"Inherited factor XIII deficiency: diagnosis, prevalence and treatment modalities in 2020","volume":"26","author":"Rugeri L","year":"2020","unstructured":"Rugeri L, Bouttefroy S, Jousselme E, Nougier C, Meunier S. Inherited factor XIII deficiency: diagnosis, prevalence and treatment modalities in 2020. Hematology. 2020, 26:192-200. 10.1684\/hma.2020.1571","journal-title":"Hematology"},{"key":"ref49","article-title":"Factor XIII deficiency","author":"Mangla A","year":"2025","unstructured":"Mangla A, Hamad H, Killeen RB, Kumar A. Factor XIII deficiency. StatPearls Publishing, Treasure Island (FL); 2025."},{"key":"ref50","article-title":"Congenital factor XIII deciciency in pregnant women (Article in French)","volume":"12","author":"Gassara H","year":"2018","unstructured":"Gassara H, Medhaffar M, Khanfir F, Frikha I, Elloumi M, Chaabane K. Congenital factor XIII deciciency in pregnant women (Article in French). . J I M Sfax. 2018, 12:15.","journal-title":". J I M Sfax"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.5482\/HAMO-13-08-0046","article-title":"Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited\u00a0and\u00a0acquired forms","volume":"34","author":"Biswas A","year":"2014","unstructured":"Biswas A, Ivaskevicius V, Thomas A, Oldenburg J. Coagulation factor XIII deficiency. Diagnosis, prevalence and management of inherited\u00a0and\u00a0acquired forms. Hamostaseologie. 2014, 34:160-6. 10.5482\/HAMO-13-08-0046","journal-title":"Hamostaseologie"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12259","article-title":"Congenital factor XIII deficiency in women: a systematic review of literature","volume":"19","author":"Sharief LA","year":"2013","unstructured":"Sharief LA, Kadir RA. Congenital factor XIII deficiency in women: a systematic review of literature. Haemophilia. 2013, 19:e349-57. 10.1111\/hae.12259","journal-title":"Haemophilia"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2012.01465.x","article-title":"Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke","volume":"35","author":"Antalfi B","year":"2013","unstructured":"Antalfi B, Pongr\u00e1cz E, Csiki Z, Mezei ZA, Shemirani AH. Factor XIII-A subunit Val34Leu polymorphism in fatal hemorrhagic stroke. Int J Lab Hematol. 2013, 35:88-91. 10.1111\/j.1751-553X.2012.01465.x","journal-title":"Int J Lab Hematol"},{"key":"ref54","article-title":"Thesis: Combined coagulation factor V and factor VIII deficiency: A case report and literature review. Faculty of medicine and pharmacy - Rabat. Mohammed V university","author":"Abdelilah N","year":"2013","unstructured":"Abdelilah N. Combined coagulation factor V and factor VIII deficiency: A case report and literature review (Thesis). Mohammed V University, Rabat; 2013. https:\/\/toubkal.imist.ma\/xmlui77\/bitstream\/handle\/123456789\/18783\/P0032013.pdf."},{"key":"ref55","unstructured":"Omar Bennour. Thesis. Combined deficiency of coagulation factors V and VIII. Faculty of medicine and pharmacy - Rabat. Mohammed V university. (2019). Accessed: March 01,2025: http:\/\/ao.um5.ac.ma\/xmlui\/handle\/123456789\/17694."},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01419.x","article-title":"The vitamin K cycle","volume":"3","author":"Stafford DW","year":"2005","unstructured":"Stafford DW. The vitamin K cycle. J Thromb Haemost. 2005, 3:1873-8. 10.1111\/j.1538-7836.2005.01419.x","journal-title":"J Thromb Haemost"},{"key":"ref57","unstructured":"National diagnosis and treatment protocol rare coagulation protein\u00a0deficiencies. (2021). Accessed. March 24, 2025: https:\/\/www.has-sante.fr\/upload\/docs\/application\/pdf\/2021-08\/pnds_autres_deficits_argumentaire_2021.08.pdf."},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-21","article-title":"Hereditary combined deficiency of the vitamin K-dependent clotting factors","volume":"5","author":"Napolitano M","year":"2010","unstructured":"Napolitano M, Mariani G, Lapecorella M. Hereditary combined deficiency of the vitamin K-dependent clotting factors. Orphanet J Rare Dis. 2010, 5:21. 10.1186\/1750-1172-5-21","journal-title":"Orphanet J Rare Dis"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-024-01806-7","article-title":"Diagnosis, treatment, surgical practices and review of the literature in rare coagulation factor deficiencies","volume":"51","author":"Solgun HA","year":"2025","unstructured":"Solgun HA. Diagnosis, treatment, surgical practices and review of the literature in rare coagulation factor deficiencies. Ital J Pediatr. 2025, 51:3. 10.1186\/s13052-024-01806-7","journal-title":"Ital J Pediatr"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.emcden.2003.05.001","article-title":"Physiology of hemostasis (Article in French)","volume":"1","author":"de Revel T","year":"2004","unstructured":"de Revel T, Doghmi K. Physiology of hemostasis (Article in French). EMC-Dentistry. 2004, 1:71-81. 10.1016\/j.emcden.2003.05.001","journal-title":"EMC-Dentistry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/383161-molecular-aspects-of-rare-coagulation-factor-deficiencies","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T07:15:46Z","timestamp":1753946146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/383161-molecular-aspects-of-rare-coagulation-factor-deficiencies"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,31]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.89102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,7,31]]}}}